Testing a new drug for acute gout flares
Treatments studied
Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism clinical trials.
This trial tests a new medication, ABP-745, for people having an acute gout flare. It aims to see if the drug is safe and helps reduce pain and inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been diagnosed with gout and have had at least 2 flares in the past year.
- You are currently having a gout flare that started within the last 6 months.
- Your body mass index (BMI) is between 18 and 40.
- You have not taken certain arthritis medications or steroids recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called IBI3011 to see if it can reduce pain and inflammation during an acute gout flare. It's for people whose current gout flare treatments haven't worked well or caused side effects.
This trial tests an oral medication (HRS-2129) to see if it can calm a sudden gout flare and reduce joint pain. It may help if you are currently having a moderate-to-severe gout attack and are otherwise in good health.
This study tests two doses of a medicine called Purified Cortrophin Gel for people having a gout flare that started in the last 5 days. It might be an option if other treatments haven't worked or aren't safe for you.
This trial tests a new investigational drug called plonmarlimab for people with frequent, painful gout flares who cannot take standard treatments. The goal is to see if it can reduce pain and inflammation from the flare.
This trial studies dapansutrile tablets (OLT1177) to see how well they work for people in the first 4 days of an acute gout flare. It may help reduce pain and inflammation in the specific joint where your gout is flaring.
This trial tests a new medicine, PRX-115, given through a vein, to see if it lowers uric acid levels in people with gout who haven't had success with standard treatments. Some participants will also take methotrexate, and the results are compared to a placebo (a dummy infusion).
Hear when a new Gout Flare trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.